Seres Therapeutics (MCRB) Stock Chart & Stock Price History $19.48 +1.16 (+6.30%) As of 03:29 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Seres Therapeutics Stock Price Performance The Seres Therapeutics (MCRB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 13.23%, with a year-to-date return of 17.18%. In the past month, the stock has increased 57.18%, reflecting recent market activity. As of the latest close, Seres Therapeutics traded at $18.32 with a market cap of $160.30 million and volume of 126,540 shares. Five years ago, the stock traded at a split-adjusted price of $491.60, representing a 96.04% decrease over that period. At the time, it had a market cap of $1.91 billion and a volume of 68,894 shares. Receive MCRB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Seres Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+16.69%1 Month Performance+57.18%3 Month Performance+161.76%Year-To-Date Performance+17.18%1 Year Performance+13.23%5 Year Performance-96.04% MCRB Stock Chart for Friday, August, 22, 2025 MCRB Chart by TradingView Seres Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/21/2025$17.94$18.32+2.12%$19.00$17.57126,540 shs$160.30 million08/20/2025$16.25$17.94+10.40%$18.12$16.28130,131 shs$156.98 million08/19/2025$17.69$16.25-8.14%$17.85$16.2598,341 shs$142.27 million08/18/2025$16.69$17.69+5.99%$18.12$15.79188,436 shs$154.79 million08/15/2025$16.86$16.69-1.01%$17.17$16.4955,391 shs$146.04 million08/14/2025$15.97$16.86+5.57%$17.52$15.76208,903 shs$147.53 million08/13/2025$15.44$15.97+3.43%$15.99$15.1499,670 shs$139.74 million08/12/2025$14.53$15.44+6.26%$15.44$14.3682,913 shs$135.18 million08/11/2025$14.21$14.53+2.25%$15.84$14.06122,694 shs$127.14 million08/08/2025$15.29$14.21-7.06%$15.55$14.09105,268 shs$124.05 million Get the Latest News and Ratings for MCRB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Seres Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/07/2025$13.78$15.29+10.96%$15.96$14.19289,291 shs$133.48 million08/06/2025$14.28$13.78-3.50%$15.45$13.51116,537 shs$120.33 million08/05/2025$14.78$14.28-3.38%$15.38$14.11147,475 shs$124.66 million08/04/2025$13.99$14.78+5.65%$14.85$13.7883,419 shs$129.03 million08/01/2025$14.26$13.99-1.89%$14.10$13.3847,064 shs$122.13 million07/31/2025$14.40$14.26-0.97%$15.40$14.01116,794 shs$124.52 million07/30/2025$12.15$14.40+18.52%$14.40$12.24125,002 shs$125.71 million07/29/2025$13.24$12.15-8.23%$13.55$12.1571,900 shs$106.07 million07/28/2025$14.53$13.24-8.88%$15.07$13.15142,966 shs$115.61 million07/25/2025$13.40$14.53+8.43%$15.41$13.32247,698 shs$126.88 million07/24/2025$13.09$13.40+2.37%$13.67$12.6977,316 shs$116.98 million07/23/2025$12.39$13.09+5.65%$13.20$12.50168,975 shs$114.28 million07/22/2025$13.85$12.39-10.54%$13.70$11.15268,878 shs$108.17 million07/21/2025$14.07$13.85-1.56%$14.68$13.8075,119 shs$122.87 million Related Companies ORKA Stock Chart SLDB Stock Chart KURA Stock Chart PRME Stock Chart ARVN Stock Chart ETON Stock Chart SVRA Stock Chart PVLA Stock Chart ITOS Stock Chart SNDL Stock Chart Receive MCRB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Seres Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MCRB) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersSilver’s Still Under $35… For Now.Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...GoldenCrest Metals | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Seres Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Seres Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access